New diabetes clinical trial: Quadruple Oral Combination Therapy for Type 2 Diabetes Mellitus : Glycemic Control by Thiazolidinedione (TZD) or Sodium Glucose Co-transporter 2 (SGLT-2) Inhibitor as an add-on Therapy in Type 2 Diabetes Mellitus After Failure of an Oral Triple Antidiabetic Regimen

Published on: July 09, 2019 at 07:00PM
Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: TZD group;   Drug: SGLT-2 group
Sponsor:   Yonsei University
Not yet recruiting